Global Oral Proton Pump Inhibitors (PPIs) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Oral Proton Pump Inhibitors (PPIs) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Proton pump inhibitors (PPIs) are a group of medicines that decrease stomach acid production. They can help relieve symptoms of chronic acid reflux (GERD) and stomach ulcers. Proton pump inhibitors primarily treat conditions that arise when stomach acid irritates or damages parts of the digestive system, like stomach, duodenum (the part of your small intestine closest to the stomach) or food tube (esophagus).

According to our (Global Info Research) latest study, the global Oral Proton Pump Inhibitors (PPIs) market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global Oral Proton Pump Inhibitors (PPIs) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Oral Proton Pump Inhibitors (PPIs) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030

Global Oral Proton Pump Inhibitors (PPIs) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030

Global Oral Proton Pump Inhibitors (PPIs) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030

Global Oral Proton Pump Inhibitors (PPIs) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Oral Proton Pump Inhibitors (PPIs)

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Oral Proton Pump Inhibitors (PPIs) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda Pharmaceutical, Pfizer, AstraZeneca, Eisai Co., Cipla Ltd., Aurobindo Pharma, Teva, Hetero Drugs, Nang Kuang Pharmacutical, Jean Marie Pharmacal, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Oral Proton Pump Inhibitors (PPIs) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Rabeprazole
Ilaprazole
Esomeprazole
Omeprazole
Pantoprazole
Others

Market segment by Application
Hospital Pharmacy
Retail Pharmacy

Major players covered
Takeda Pharmaceutical
Pfizer
AstraZeneca
Eisai Co.
Cipla Ltd.
Aurobindo Pharma
Teva
Hetero Drugs
Nang Kuang Pharmacutical
Jean Marie Pharmacal
Lizhu Group
Luoxin Pharmaceutical
Jiangsu Haosen Pharmaceutical Group
Chengdu Dikang Pharmaceutical
Jumpcan Pharmaceutical

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Oral Proton Pump Inhibitors (PPIs) product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Oral Proton Pump Inhibitors (PPIs), with price, sales quantity, revenue, and global market share of Oral Proton Pump Inhibitors (PPIs) from 2019 to 2024.

Chapter 3, the Oral Proton Pump Inhibitors (PPIs) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Oral Proton Pump Inhibitors (PPIs) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Oral Proton Pump Inhibitors (PPIs) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Proton Pump Inhibitors (PPIs).

Chapter 14 and 15, to describe Oral Proton Pump Inhibitors (PPIs) sales channel, distributors, customers, research findings and conclusion.